Papakostas, George I.

Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group

Chen, J. A., Papakostas, G. I., Youn, S. J., Baer, L., Clain, A. J., Fava, M., & Mischoulon, D. (2011) · The Journal of Clinical Psychiatry

Pain Management and Placebo EffectPsychotherapy Techniques and Applications

Cited by 56

Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder

Levkovitz, Y., Alpert, J. E., Brintz, C. E., Mischoulon, D., & Papakostas, G. I. (2012) · Journal of Affective Disorders

Treatment of Major DepressionTryptophan and brain disorders

Cited by 51

Tachyphylaxis in major depressive disorder: A review of the current state of research

Kinrys, G., Gold, A. K., Pisano, V. D., Freeman, M. P., Papakostas, G. I., Mischoulon, D., Nierenberg, A. A., & Fava, M. (2019) · Journal of Affective Disorders

Treatment of Major DepressionPsychological Treatments and Disorders

Cited by 45

Type of residual symptom and risk of relapse during the continuation/maintenance phase treatment of major depressive disorder with the selective serotonin reuptake inhibitor fluoxetine

Yang, H., Chuzi, S., Sinicropi-Yao, L., Johnson, D., Chen, Y., Clain, A., Baer, L., McGrath, P. J., Stewart, J. W., Fava, M., et al. (2010) · European Archives of Psychiatry and Clinical Neuroscience

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 42

Anxious depression and early changes in the HAMD-17 anxiety-somatization factor items and antidepressant treatment outcome.

Farabaugh, A. H., Bitran, S., Witte, J., Alpert, J., Chuzi, S., Clain, A. J., Baer, L., Fava, M., McGrath, P. J., Dording, C., et al. (2010) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 37

Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study

Yoo, I., Woo, J.-M., Lee, S.-H., Fava, M., Mischoulon, D., Papakostas, G. I., Kim, E.-J., Chung, S., Ha, J. H., & Jeon, H. J. (2015) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 15

The Role of Cognitive-Behavioral Therapy and Fluoxetine in Prevention of Recurrence of Major Depressive Disorder

Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., et al. (2010) · Cognitive Therapy and Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 14

Ziprasidone augmentation for anxious depression

Ionescu, D. F., Shelton, R. C., Baer, L., Meade, K. H., Swee, M. B., Fava, M., & Papakostas, G. I. (2016) · International Clinical Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 10

Differences in cognitive factors between “true drug” versus “placebo pattern” response to fluoxetine as defined by pattern analysis

Farabaugh, A. H., Sonawalla, S. B., Fava, M., Pedrelli, P., Papakostas, G. I., Schwartz, F., & Mischoulon, D. (2006) · Human Psychopharmacology: Clinical and Experimental

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 8

Efficacy of ziprasidone monotherapy in patients with anxious depression: a 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial

Heo, J.-Y., Jeon, H. J., Fava, M., Mischoulon, D., Baer, L., Clain, A., Doorley, J., Pisoni, A., & Papakostas, G. I. (2015) · Journal of Psychiatric Research

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 6